Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gudlaugsdottir

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|July 4, 2001
A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillanceS Gudlaugsdottir, M van Blankenstein, J Dees, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 24, 2012
Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control studyI Vesteinsdottir, S Gudlaugsdottir, R Einarsdottir, et al.
Diagnostic Cytopathology|May 2, 2000
P53 mutations analysis in benign and malignant breast lesions: using needle rinses from fine-needle aspirationsS Gudlaugsdottir, V Sigurdardottir, M Snorradottir, et al.
Laeknabladid|January 13, 2010
[DNA flow cytometry is a useful prognostic guide in the treatment of breast cancer.]S Gudlaugsdottir, H Sigurdsson, B A Agnarsson, et al.
Cancer Research|March 21, 1998
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instabilityS Gretarsdottir, S Thorlacius, R Valgardsdottir, et al.
Journal of Medical Genetics|July 13, 2002
The effect of a single BRCA2 mutation on cancer in IcelandH Tulinius, G H Olafsdottir, H Sigvaldason, et al.
Genes, Chromosomes & Cancer|June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics ConsortiumK Laake, V Launonen, D Niederacher, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|July 4, 2001
A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillanceS Gudlaugsdottir, M van Blankenstein, J Dees, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 24, 2012
Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control studyI Vesteinsdottir, S Gudlaugsdottir, R Einarsdottir, et al.
Diagnostic Cytopathology|May 2, 2000
P53 mutations analysis in benign and malignant breast lesions: using needle rinses from fine-needle aspirationsS Gudlaugsdottir, V Sigurdardottir, M Snorradottir, et al.
Laeknabladid|January 13, 2010
[DNA flow cytometry is a useful prognostic guide in the treatment of breast cancer.]S Gudlaugsdottir, H Sigurdsson, B A Agnarsson, et al.
Cancer Research|March 21, 1998
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instabilityS Gretarsdottir, S Thorlacius, R Valgardsdottir, et al.
Journal of Medical Genetics|July 13, 2002
The effect of a single BRCA2 mutation on cancer in IcelandH Tulinius, G H Olafsdottir, H Sigvaldason, et al.
Genes, Chromosomes & Cancer|June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics ConsortiumK Laake, V Launonen, D Niederacher, et al.
Pageof 1